REV-ERBα reduction is associated with clinicopathological features and prognosis in human gastric cancer

Oncology Letters
Xiaoshan WangZhengguang Wang

Abstract

Gastric cancer is a serious threat to human health. Nuclear receptor subfamily 1 group D member 1 (REV-ERBα) is a member of the nuclear hormone receptor family that regulates lipid metabolism, inflammatory responses and circadian rhythms. However, the role of REV-ERBα in the pathogenesis of human gastric cancer is unclear. The present study employed gastric cancer tissues from 74 patients and determined the association between REV-ERBα expression with clinicopathological variables and prognosis. Furthermore, the association between REV-ERBα and apoptosis in undifferentiated and moderately differentiated human gastric cancer cells was determined. It was identified that REV-ERBα expression was decreased in gastric cancer, which was positively associated with poor differentiation (P=0.009), T stage (P=0.001), Tumor-Node-Metastasis (TMN) stage (P=0.001) and lymph node metastasis (P=0.007). In the survival analysis, the 3- and 5-year survival times of patients were significantly associated with REV-ERBα expression (P=0.009 and P=0.002, respectively). Low REV-ERBα expression was associated with poor prognosis (P<0.05). Concurrently, cleaved caspase-3 expression was downregulated, whereas expression levels of Bcl-2 and the Bcl-2/Bax r...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jun 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jin Hyup Lee, Aziz Sancar
Aug 1, 2013·Progress in Molecular Biology and Translational Science·Loning Fu, Nicole M Kettner
Aug 7, 2013·Trends in Cell Biology·Carrie L PartchJoseph S Takahashi
Aug 15, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Gianluigi MazzoccoliManlio Vinciguerra
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Jun 16, 2015·Biochemical Pharmacology·Yongjun WangThomas P Burris
Sep 4, 2015·Diabetes, Obesity & Metabolism·E VieiraI Quesada
Oct 17, 2015·Scientific Reports·Weiwei TaoChao-Jun Li
Oct 27, 2015·Molecular and Cellular Biochemistry·Yan WuZhengguang Wang
Jun 28, 2016·Trends in Molecular Medicine·Paula Gutierrez-MartinezIsabel Beerman
Jun 28, 2016·Advances in Clinical Chemistry·E Reszka, M Przybek
Feb 19, 2017·Biochemical Pharmacology·Sadichha SitaulaThomas P Burris

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence microscopy

Software Mentioned

SPSS
Quantity one
IPWIN Application

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.